A wholly owned subsidiary of the Abu Dhabi Investment  Authority (“ADIA”) has entered into definitive agreements to invest USD 200 million for a  ~3% stake in Micro Life Sciences Private Limited (“Meril”), one of India’s leading medical  devices companies. This investment values Meril at an enterprise value of USD 6.6  billion. The transaction is subject to regulatory approval by the Competition Commission  of India (CCI). Post this investment, Meril will be backed by two globally recognized  investors, ADIA and Warburg Pincus. 

Founded by the Bilakhia Group, Meril is a global innovator in medical technology  (MedTech), with a strong focus on clinically advanced solutions across multiple  specialties - including Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery,  In-vitro Diagnostics and Surgical Robotics.